Related Experiment Video
Updated: Aug 23, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade
Josep M Campistol1, Rafael Romero, Javier Paul
1Renal Transplant Unit, Hospital Clinic, University of Barcelona, 170, Villarroel, 08036, Barcelona, Spain. jmcampis@clinic.ub.es
Insights
Arterial hypertension is common after renal transplantation, but control has improved. Newer treatments like tacrolimus and increased use of ACE inhibitors/ATII blockers show better outcomes.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Arterial hypertension is a prevalent issue in renal transplant recipients.
- It significantly impacts graft and patient survival rates.
- Effective management is crucial for long-term outcomes.
Purpose of the Study:
- To analyze trends in arterial hypertension prevalence and management post-renal transplantation.
- To identify factors associated with hypertension development.
- To evaluate the impact of different immunosuppressive therapies on hypertension.
Main Methods:
- Retrospective analysis of 3365 adult renal transplant recipients from 1990, 1994, and 1998.
- Hypertension defined as SBP ≥140 mmHg, DBP ≥90 mmHg, or antihypertensive drug use.
- Recorded use of ACE inhibitors or ATII receptor blockers and immunosuppressive agents.
Main Results:
- Hypertension prevalence increased over time, but blood pressure levels were lower in 1998.
- Factors associated with hypertension included male gender, younger donor age, cyclosporine use, and higher creatinine.
- Tacrolimus use was associated with lower hypertension prevalence and severity compared to cyclosporine.
- Use of ACE inhibitors/ATII receptor blockers increased significantly.
Conclusions:
- Arterial hypertension remains a significant challenge in renal transplantation.
- Recent management strategies show improved control, with satisfactory intensity.
- Increased utilization of ACE inhibitors and ATII receptor blockers is noted.
Background:
Arterial hypertension is a common clinical problem in renal transplantation, with important consequences on graft and patient survival.
Patients And Methods:
A total of 3365 adult patients transplanted in 1990 (N = 824), 1994 (N = 1075) and 1998 (N = 1466) with a functioning graft after the first year were included. In this study, arterial hypertension was defined as systolic blood pressure (SBP) > or =140 mmHg and/or diastolic blood pressure (DBP) > or =90 mmHg and/or treatment with antihypertensive drugs. The use of angiotensin converting enzyme (ACE) inhibitors or angiotensin II (ATII) receptor blockers during the first year was recorded.
Results:
The prevalence of hypertension showed a progressive and significant increase during follow-up after renal transplantation in the three periods analysed, although SBP and DBP were lower in patients who underwent transplantation in 1998. The presence of arterial hypertension at 1 year was significantly associated with recipient gender (male), donor age (< 60 years), immunosuppressive therapy (cyclosporine), serum creatinine and year of transplantation. Arterial hypertension was not associated with graft survival and cardiovascular mortality. The prevalence and severity of hypertension was significantly lower in patients treated with tacrolimus vs cyclosporine. The use of ACE inhibitors or ATII receptor blockers has increased in the recent years.
Conclusions:
Arterial hypertension remained a common problem in renal transplantation, although in recent years the intensity of the control seems satisfactory. The use of ACE inhibitors or ATII receptor blockers has increased significantly in the last years.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Kidney Transplant I: Introduction
Hypertension II: Pathophysiology
Kidney Transplant III: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
